The usual private-equity tour of a medical practice begins in a spreadsheet. Amjad Hammad would rather start in the clinic. A retina surgeon and healthcare entrepreneur, Hammad founded Baraka Prosperity Partners with healthcare operator Taleb Hammad around a plain observation: the economics of care are inseparable from the people delivering it and the rooms where it happens. Referral patterns, clinical workflow, physician retention, compliance, rent and patient access do not live in separate columns. They meet every morning in the waiting room.
From Saratoga Springs, New York, the young firm is assembling an investment platform around that intersection. Its public strategy assigns 40 percent to management services organizations and other operating platforms, 30 percent to healthcare real estate, 20 percent to international healthcare ventures and 10 percent to cash or opportunistic investments. The numbers are targets, not a report of capital already deployed. They nevertheless make the thesis unusually easy to see: operations come first, property supports them, international projects widen the field and liquidity keeps the vehicle flexible.
The core proposition
Owning the care around the care
Baraka is not selling a consumer app or a single medical service. Its product is an evergreen private-market vehicle offered to accredited investors through confidential placement documents. Inside that vehicle, the firm proposes to build or back the administrative layer around physicians, acquire or develop the places where they work, pursue selected overseas projects and reinvest proceeds rather than wind everything down on a conventional fund clock.
The operating-platform piece centers on MSOs, or management services organizations. An MSO can take payroll, billing, compliance, purchasing, marketing and other non-clinical work off a doctor's desk. In theory, clinicians get more time for patients while the shared platform gains recurring revenue and scale. Baraka points to EyeStudioNY as an example from its founders' operating record: a multi-location model combining optometry, urgent eye care and retail optical services. The mix turns a familiar shopfront into a small care ecosystem, with clinical and retail activity under physician leadership.
“We view governance as the product.”Baraka Prosperity Partners, on private markets
Then there is the building. Medical offices look like real estate, but their value depends on healthcare behavior: which specialists need proximity, whether a procedure can move from a hospital to an outpatient setting, how long a practice will remain and whether patients can reach the site. Baraka's argument is that a physician-operator can read those signals with more texture than a generalist landlord. The firm identifies medical office buildings, ambulatory surgical centers and mixed-use medical hubs as targets.
A portfolio drawn like a floor plan
A working example
Maple Commons, with a clinic downstairs
The firm's most tangible public case study is Maple Commons in Wilton, New York. Baraka describes the mixed-use development as a $46 million project with 127 residential units and 31,000 square feet of pre-leased medical and retail space. Housing supplies everyday foot traffic; healthcare tenants provide long leases and a reason for the site to matter beyond its apartments. It is a compact illustration of Baraka's preferred overlap between community infrastructure and medical demand.
Other names on the public pipeline remain earlier. The firm lists a Tampa medical office and multi-specialty MSO, a Glens Falls medical-office feasibility project and an Upstate New York MSO focused on J-1 physicians. That last idea is particularly revealing. International medical graduates serving under J-1 visa pathways are important to many underserved communities, but practices face recruitment, immigration and operating complexity. A shared platform could turn those frictions into a focused service. Baraka has described the project as early-stage, so the test is still ahead.
Abroad, Baraka has outlined primary-care, diagnostics and possible public-private projects in Jordan. This is not simply geographic diversification. It connects the firm's healthcare operating thesis to Islamic capital markets, where it believes large pools of values-aligned capital have yet to become a reliable financing system for health infrastructure. The ambition appears in Baraka Insights, a publication platform launched in 2026 for research on healthcare infrastructure, governance, Islamic finance and cross-border capital.
The difference
Ethics as operating architecture
Plenty of investors specialize in healthcare. Others own medical offices. Still others screen portfolios according to Islamic-finance rules. Baraka's distinction is the attempt to combine all three, led by people who have run clinical businesses. The framework is expressed through three Arabic words: amanah, trust; niyyah, intention; and ihsan, excellence. The name Baraka itself means blessing or prosperity.
Those words matter only if they change behavior. Baraka says its ethical framework excludes prohibited or harmful industries, includes income-purification protocols when needed and draws oversight from faith-based scholars. On the fund side, it describes third-party administration, assets held in segregated Chase Bank accounts, annual independent audits, quarterly net-asset-value updates and an LP advisory board that reviews strategy and related-party transactions. Final authority remains with the general partners.
That governance emphasis is more than a compliance detail because private assets do not offer a daily market price or an easy exit. Investors must trust how a manager values an unfinished building, allocates expenses across affiliated companies and handles a clinic that needs more capital. Baraka's structure makes transparency part of what it sells. The secure portal provides documents, capital tracking, performance dashboards and periodic reporting, according to the firm.
Its evergreen design is the other structural choice. A traditional private-equity fund often needs to return capital within a fixed life, which can force a sale even when an asset is still improving. An evergreen vehicle can hold, reinvest and add future assets to the same portfolio. That can suit a medical campus or physician network that takes years to assemble. It also asks investors to accept less natural liquidity and puts greater weight on consistent valuation. Patience is useful only when the controls around it work.
Who it serves
Two customers, one long clock
Baraka effectively serves two constituencies. Accredited investors and limited partners are the capital customers, particularly those seeking private healthcare exposure with an ethical or Islamic-finance alignment. Physicians and healthcare entrepreneurs are the operating customers: they may need capital, centralized services, property or a partner able to speak both clinical and financial language. Patients and local communities are downstream beneficiaries, though their experience will be the practical measure of whether the strategy delivers more than attractive assets.
The founders bring relevant, if closely held, experience. Amjad Hammad is a retina surgeon who founded EyesNY and EyeStudioNY. Taleb Hammad is a healthcare operator with more than two decades in physician-group management and compliance. Baraka also points to Amjad's pre-fund special-purpose vehicle investment in Galaxy Therapeutics, a neurovascular-device company. The firm says the SPV deployed $5.5 million over several tranches from seed-stage bench testing through the final FDA premarket-approval submission for Galaxy's SEAL device. It is evidence of clinical conviction across a long development arc, not proof that Baraka's newer fund has reached scale.
That distinction matters. Baraka was founded in 2025, LinkedIn describes a team in the two-to-ten range, and neither current assets under management nor fund returns are public. The company presents a goal of exceeding $100 million in AUM within five to six years. Several portfolio items are active pipelines rather than completed investments. This is an emerging manager story, built partly on the founders' earlier operating and investing record.
The market will judge execution in ordinary details: whether physicians actually share services, whether planned buildings secure tenants, whether international projects move beyond proposals and whether reporting remains clear as related businesses multiply. The integrated model creates useful information, but it can also create conflicts and concentration. Independent valuation and advisory review are therefore load-bearing parts of the design, not ornaments around it.
Where it fits
The quiet machinery of outpatient care
Baraka sits between healthcare private equity, medical-office investing and impact-oriented finance. A physician selling to a large practice aggregator might see it as an operator-friendly alternative. An investor choosing between a healthcare fund and a real-estate vehicle might see it as both, with the concentration that implies. A values-aligned allocator might see a rare private-market product built explicitly around Islamic-finance governance rather than applying a screen after the portfolio is assembled.
The opportunity is mundane in the best sense. Healthcare delivery depends on billing teams, leases, diagnostic rooms, surgery centers and practitioners willing to stay. These are not moonshots. They are durable systems with complicated incentives. Baraka's useful wager is that the people who understand those systems can be more than expert witnesses for somebody else's fund. They can decide what gets built, operate it and remain alongside the capital long enough to see whether the waiting room fills.